(November 19, 2020) Bethesda, MD – The Bladder Cancer Advocacy Network (BCAN) is pleased to announce that Duncan Alexander has been elected to its Board of Directors. “Mr. Alexander has been a leader in the business community and brings valued expertise to the Board in addition to his history of
All Posts by Mark Story
Burt’s Story: When I heard the words “You have bladder cancer,” it was a gut punch
I am a nephrologist and have been practicing medicine since 1976, so I look at my bladder cancer journey somewhat differently than others might. I was having some difficulty urinating and in the process of having my prostate looked at, my doctor came out afterwards and said, “Oh, by the
Statement on Planned Merck BCG Production Facility to Expand Capacity
October 14, 2020 From Andrea Maddox-Smith, CEO: Today’s news that Merck has announced construction of a new manufacturing facility to significantly expand its production capacity for TICE® BCG is welcome news for bladder cancer patients. We appreciate Merck’s commitment to increase the supply of a treatment that is in such
Bladder Cancer Advocacy Network Statement on Golfer John Daly’s Bladder Cancer Diagnosis
(September 11. 2020 BETHESDA, MD) – The Bladder Cancer Advocacy Network (BCAN) was saddened to learn of the bladder cancer diagnosis of professional golfer John Daly. According to an interview with the Golf Channel, Mr. Daly stated that he had recently been suffering from back pains and said these issues
2020 Information About the BCG Shortage
September 2020 Last year, BCAN and its partners shared a message regarding the global shortage of Merck’s TICE BCG due to an increasing global demand for the product. The American Urological Association (AUA), American Association of Clinical Urologists (AACU), Bladder Cancer Advocacy Network (BCAN), Society of Urologic Oncology (SUO), the
Protected: Virtual Think Tank 2020 Meeting Video
There is no excerpt because this is a protected post.
Our Legislative Priorities
The Bladder Cancer Advocacy Network helps serve as a voice for those impacted by bladder cancer. Since 2005, we have been strong advocates for our community. Our legislative priorities include: Increase federal research funding for bladder cancer BCAN supports efforts to increase the budget of the NIH and the National
Bladder Cancer Advocacy Network Announces 2020 Bladder Cancer Research Innovation Awardee
$300,000 Award Fuels Bladder Cancer Research Innovation FOR IMMEDIATE RELEASE: (June 22, 2020: Bethesda, MD) Today, the Bladder Cancer Advocacy Network (BCAN) announced the recipient of its prestigious Bladder Cancer Research Innovation Award. This year’s awardee is Jeffrey Ravetch, MD, PhD, Professor and Head of the Laboratory of Molecular Genetics
The Bladder Cancer Advocacy Network Announces Awardees of Its 2020 New Discoveries Young Investigator Awards
Awardees recognized for novel, early career research that improves the understanding and treatment of bladder cancer FOR IMMEDIATE RELEASE: May 14, 2020 Bethesda, MD – The Bladder Cancer Advocacy Network (BCAN) today announced the recipients of its three New Discoveries Research Young Investigator Awards, supporting the development of outstanding early